Subscribe to RSS Feed
Tough decision for Roche following mixed Phase II Trial results for Alzheimer’s drug, says GlobalData Analyst
• Roche faces difficult decision over entering Alzheimer’s disease (AD) drug crenezumab for Phase III clinical trials
Highlights of the 25th Congress of the European College of Neuropsychopharmacology (ECNP) 2012
Europe’s leading voice for research on disorders of the brain: celebrating a quarter-century at the cutting edge
Suicide in children and adolescents
Europe’s leading voice for research on disorders of the brain celebrates its 25-year anniversary
People living with Multiple Sclerosis (MS) face huge inequalities in access, quality and cost of care across Europe
Brussels, 24 April 2012 – Growing disparities in Multiple Sclerosis (MS) care across Europe were highlighted today in the European Parliament, by Romanian MEP...
Unlocking Autism's Mysteries: New Brain Imaging and Computer Modelling used To Predict Autistic Brain Activity and Behaviour
Predictions Will Provide Scientists With Clear Targets for Autism Intervention and Treatment Therapies.
Treat insomnia early to reduce risk of developing other illnesses
Insomnia is the most common sleep disorder, but despite advances in diagnosis and management it often goes unrecognised and untreated. Left untreated, insomnia...
Prenatal use of newer antiepileptic drugs not associated with increased risk of major birth defectsPrenatal use of newer antiepileptic drugs not associated with increased risk of major birth defects
Use of newer-generation antiepileptic drugs, which are also prescribed for bipolar mood disorders and migraine headaches, during the first trimester of...